atai Life Sciences N.V. (ATAI) Just Flashed Golden Cross Signal: Do You Buy? — Positive
ATAI Zacks Investment Research — May 22, 2025Atai Life Sciences N.V. (ATAI) reached a significant support level, and could be a good pick for investors from a technical perspective.
Should You Buy O-I Glass (OI) After Golden Cross? — Positive
OI Zacks Investment Research — May 22, 2025O-I Glass, Inc. (OI) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, OI's 50-day simple moving average broke out above its 200-day moving average; this is known as a "golden cross.
BancFirst (BANF) Just Flashed Golden Cross Signal: Do You Buy? — Positive
BANF Zacks Investment Research — May 22, 2025After reaching an important support level, BancFirst Corporation (BANF) could be a good stock pick from a technical perspective. BANF recently experienced a "golden cross" event, which saw its 50-day simple moving average breaking out above its 200-day simple moving average.
After Golden Cross, First Savings Financial (FSFG)'s Technical Outlook is Bright — Positive
FSFG Zacks Investment Research — May 22, 2025First Savings Financial Group, Inc. (FSFG) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, FSFG's 50-day simple moving average broke out above its 200-day moving average; this is known as a "golden cross.
Wall Street Analysts See a 25.14% Upside in First Community (FCCO): Can the Stock Really Move This High? — Positive
FCCO Zacks Investment Research — May 22, 2025The mean of analysts' price targets for First Community (FCCO) points to a 25.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Wall Street Analysts Believe Bilibili (BILI) Could Rally 26.89%: Here's is How to Trade — Positive
BILI Zacks Investment Research — May 22, 2025The consensus price target hints at a 26.9% upside potential for Bilibili (BILI). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Wall Street Analysts Think Centerra Gold (CGAU) Could Surge 27.33%: Read This Before Placing a Bet — Positive
CGAU Zacks Investment Research — May 22, 2025The mean of analysts' price targets for Centerra Gold (CGAU) points to a 27.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Why Burlington Stores (BURL) is a Top Growth Stock for the Long-Term — Positive
BURL Zacks Investment Research — May 22, 2025Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Booking Holdings (BKNG) is a Top Growth Stock for the Long-Term — Positive
BKNG Zacks Investment Research — May 22, 2025The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Tenet Healthcare (THC) is a Top-Ranked Growth Stock: Should You Buy? — Positive
THC Zacks Investment Research — May 22, 2025Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Yum Brands (YUM) is a Top Growth Stock for the Long-Term — Positive
YUM Zacks Investment Research — May 22, 2025Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Shake Shack (SHAK) is a Top Growth Stock for the Long-Term — Positive
SHAK Zacks Investment Research — May 22, 2025The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
RTX's Unit Secures a Contract to Aid AIM-9X Sidewinder Missile Systems — Neutral
RTX Zacks Investment Research — May 22, 2025RTX's unit, Raytheon, secures a contract to aid the AIM-9X Systems for the U.S. Navy, Air Force, Army and Foreign Military Sales customers.
Why Paypal (PYPL) is a Top Momentum Stock for the Long-Term — Positive
PYPL Zacks Investment Research — May 22, 2025Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Advanced Energy Industries (AEIS) is a Strong Momentum Stock — Positive
AEIS Zacks Investment Research — May 22, 2025Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why CF Industries (CF) is a Top Momentum Stock for the Long-Term — Positive
CF Zacks Investment Research — May 22, 2025The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why Hancock Whitney (HWC) is a Strong Momentum Stock — Positive
HWC Zacks Investment Research — May 22, 2025The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why Kinross Gold (KGC) is a Strong Momentum Stock — Positive
KGC Zacks Investment Research — May 22, 2025Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why First Horizon National (FHN) is a Strong Momentum Stock — Positive
FHN Zacks Investment Research — May 22, 2025The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Investors Urged to Contact Levi & Korsinsky for Information Before May 27, 2025 - Actinium Pharmaceuticals, Inc. (ATNM) — Neutral
ATNM Accesswire — May 22, 2025NEW YORK, NY / ACCESS Newswire / May 22, 2025 / If you suffered a loss on your Actinium Pharmaceuticals, Inc. (NYSE:ATNM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/actinium-lawsuit-submission-form?prid=149786&wire=1&utm_campaign=5 or contact Joseph E. Levi, Esq.
